Abstract
Phase 2 Study of Normal Tissue Tolerance-Adapted 5-Fraction Stereotactic Body Radiation Therapy (SBRT) for Extracranial Oligometastases
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have